Lawmakers and regulators should increase their oversight of commercial health plans and enact fair and patient-friendly reforms, writes AHA President and CEO Rick Pollack in an advertorial published today in the Wall Street Journal. 

“Major commercial insurers have implemented a number of policies that compromise patient care, access and safety,” he writes. “These include frequent changes to coverage, limited provider networks, delays in authorizing treatment and failure to pay providers in a timely manner. … These policies blindside patients and put their health at risk. They also add billions of dollars in added costs to the health care system and contribute to clinician burnout.”

For example, the advertorial highlights recent AHA efforts to prevent UnitedHealthcare from retroactively denying coverage for some emergency department care and Anthem from delaying payments to hospitals, and support for bipartisan legislation to require Medicare Advantage plans to approve coverage for care in a timely manner and policies to protect patient access to specialty drugs. 

Related News Articles

Headline
The AHA today voiced support to Senate and House sponsors of the Improving Seniors’ Timely Access to Care Act, legislation that would reduce the variation in…
Headline
The Department of Health and Human Services May 20 announced it has identified specific pricing targets for pharmaceutical manufacturers to meet to satisfy…
Headline
As Congress weighs significant changes and cuts to Medicaid, the AHA today hosted a Capitol Hill briefing for congressional staff featuring hospital and health…
Headline
The House Budget Committee May 16 voted 21-16 against advancing the fiscal year 2025 budget reconciliation bill, with five Republicans joining all Democrats in…
Perspective
Public
Three key House committees — Energy and Commerce, Ways and Means, and Agriculture — after long debates and discussions this week advanced their portions of a…
Headline
The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation…